Clinical Trial Update: WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics

View source ↗

Summary

Completed clinical trial WEUKBRE5555 under the IMI PROTECT program evaluating liver injury in antibiotic use for bacterial infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Status: COMPLETED